In 2023 the FDA updated the requirements for some GLP1 drugs to include a warning for ileus, intestinal blockage, a rare, but potentially-fatal complication
Changes of dipeptidyl peptidase IV (DPP-IV) in obese children with weight loss: relationships to peptide YY, pancreatic peptide, and insulin sensitivity
Personalized dosing We take an individualized approach to dosing rather than using a standard protocol
The volume of the cagrilintide pharmaceutical formulation present in the proximal chamber can be 200-300 l, for example 250-300 l
How do I know if its working
Risk ratios (RR) for nonfatal myocardial infarction estimates according to direct (DPP-4 inhibitors, GLP-1RA and SGLT-2 inhibitors against placebo) and indirect (DPP-4 inhibitors vs GLP-1RA or SGLT-2 inhibitors, and GLP-1RA vs SGLT-2 inhibitors) comparisons